Der Kamp Hilde Johanna Van serves as Executive at NewAmsterdam Pharma Co N.V., where they oversee executive responsibilities. Since joining the company, Der Kamp Hilde Johanna Van has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 7, 2026 involved receiving (via award) 15,300 shares valued at $0.
Der Kamp Hilde Johanna Van currently holds 15,300 shares of NewAmsterdam Pharma Co N.V. (NAMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Der Kamp Hilde Johanna Van has been a net neutral trader of NAMS stock. They have purchased $0 and sold $0 worth of shares.
Der Kamp Hilde Johanna Van's most recent insider trade was on Jan 7, 2026, when they sold 15,300 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |